Diagnostics & Research
The Diagnostics & Research industry has a total of 63 stocks, with a combined market cap of $791.44 billion, total revenue of $155.94 billion and a weighted average PE ratio of 59.26.
Market Cap
791.44B
Revenue
155.94B
Profits
13.36B
PE Ratio
59.26
Profit Margin
8.57%
Dividend Yield
0.19%
63 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 228.35B | -0.31% | 965,967 | 42.49B |
| 2 | DHR | Danaher Corporation | 196.25B | 0.52% | 2,504,327 | 22.52B |
| 3 | A | Agilent Technologies, Inc. | 45.24B | 0.15% | 842,097 | 6.74B |
| 4 | IDXX | IDEXX Laboratories, Inc. | 44.89B | -1.38% | 377,891 | 3.72B |
| 5 | IQV | IQVIA Holdings Inc. | 42.86B | 0.56% | 735,563 | 15.07B |
| 6 | MTD | Mettler-Toledo International Inc. | 32.65B | 0.70% | 100,221 | 3.79B |
| 7 | ICLR | ICON PLC | 26.13B | -1.86% | 190,701 | 8.23B |
| 8 | WAT | Waters Corporation | 21.47B | -0.35% | 264,398 | 2.91B |
| 9 | ILMN | Illumina, Inc. | 18.26B | -0.48% | 637,184 | 4.49B |
| 10 | LH | Laboratory Corporation of America Holdings | 18.03B | -0.04% | 494,960 | 12.30B |
| 11 | DGX | Quest Diagnostics Incorporated | 15.84B | 1.17% | 708,674 | 9.29B |
| 12 | RVTY | Revvity, Inc. | 13.34B | 1.07% | 855,086 | 2.73B |
| 13 | NTRA | Natera, Inc. | 13.34B | 1.11% | 824,013 | 1.21B |
| 14 | MEDP | Medpace Holdings, Inc. | 12.24B | -3.10% | 119,340 | 1.96B |
| 15 | CRL | Charles River Laboratories International, Inc. | 11.61B | -3.36% | 1,074,435 | 4.11B |
| 16 | QGEN | Qiagen N.V. | 10.17B | 0.48% | 889,680 | 1.94B |
| 17 | EXAS | Exact Sciences Corporation | 9.59B | -2.61% | 2,068,101 | 2.53B |
| 18 | RDNT | RadNet, Inc. | 4.25B | -1.13% | 202,293 | 1.66B |
| 19 | SHC | Sotera Health Company | 3.24B | - | 361,451 | 1.08B |
| 20 | GH | Guardant Health, Inc. | 3.20B | 1.90% | 2,821,973 | 603.73M |
| 21 | OLK | Olink Holding AB (publ) | 2.97B | -0.25% | 292,315 | 170.89M |
| 22 | NEOG | Neogen Corporation | 2.91B | 0.83% | 1,594,652 | 929.24M |
| 23 | TWST | Twist Bioscience Corporation | 2.71B | -3.85% | 440,981 | 277.49M |
| 24 | MYGN | Myriad Genetics, Inc. | 2.24B | -0.20% | 654,296 | 774.20M |
| 25 | NEO | NeoGenomics, Inc. | 1.92B | -0.93% | 416,885 | 610.66M |
| 26 | VCYT | Veracyte, Inc. | 1.79B | -0.64% | 327,458 | 375.47M |
| 27 | LAB | Standard BioTools Inc. | 976.77M | -1.19% | 2,378,170 | 126.76M |
| 28 | OPK | OPKO Health, Inc. | 907.00M | -3.70% | 1,546,256 | 799.60M |
| 29 | CDNA | CareDx, Inc | 772.92M | - | 405,974 | 275.11M |
| 30 | FLGT | Fulgent Genetics, Inc. | 675.24M | -0.31% | 88,527 | 287.53M |
| 31 | CSTL | Castle Biosciences, Inc. | 670.16M | -0.57% | 232,668 | 250.73M |
| 32 | ME | 23andMe Holding Co. | 289.12M | 2.07% | 2,492,395 | 247.99M |
| 33 | SERA | Sera Prognostics, Inc. | 265.42M | -0.59% | 125,677 | 206.00K |
| 34 | BDSX | Biodesix, Inc. | 178.91M | 2.30% | 73,026 | 54.85M |
| 35 | FONR | FONAR Corporation | 100.10M | -3.44% | 24,842 | 102.72M |
| 36 | PRPH | ProPhase Labs, Inc. | 96.16M | -0.58% | 74,051 | 28.72M |
| 37 | TTOO | T2 Biosystems, Inc. | 87.43M | -5.53% | 646,739 | 7.18M |
| 38 | BNR | Burning Rock Biotech Limited | 84.31M | -0.25% | 5,736 | 75.80M |
| 39 | ACRS | Aclaris Therapeutics, Inc. | 84.09M | - | 312,661 | 31.12M |
| 40 | MDXH | MDxHealth SA | 78.04M | 2.14% | 28,172 | 75.33M |
| 41 | STIM | Neuronetics, Inc. | 75.62M | 3.70% | 132,934 | 73.23M |
| 42 | PRE | Prenetics Global Limited | 72.62M | -2.01% | 21,645 | 21.74M |
| 43 | PSNL | Personalis, Inc. | 72.45M | -2.45% | 164,064 | 74.15M |
| 44 | VNRX | VolitionRx Limited | 65.55M | 1.66% | 48,489 | 797.03K |
| 45 | ENZ | Enzo Biochem, Inc. | 57.37M | 0.91% | 99,394 | 12.81M |
| 46 | NOTV | Inotiv, Inc. | 55.17M | -4.46% | 917,661 | 552.74M |
| 47 | OCX | OncoCyte Corporation | 41.03M | 6.92% | 104,552 | 1.38M |
| 48 | AWH | Aspira Women's Health Inc. | 32.97M | -5.04% | 32,844 | 8.99M |
| 49 | XGN | Exagen Inc. | 32.92M | -1.05% | 75,801 | 55.73M |
| 50 | BIAF | bioAffinity Technologies, Inc. | 27.98M | 30.32% | 400,818 | 4.94M |
| 51 | DMTK | DermTech, Inc. | 19.75M | 0.18% | 181,459 | 15.66M |
| 52 | PMD | Psychemedics Corporation | 14.86M | -7.25% | 9,828 | 21.60M |
| 53 | STRR | Star Equity Holdings, Inc. | 14.14M | -1.65% | 15,083 | 45.79M |
| 54 | MYNZ | Mainz Biomed B.V. | 14.03M | 0.63% | 264,842 | 895.48K |
| 55 | CHEK | Check-Cap Ltd. | 13.16M | 7.08% | 12,437 | - |
| 56 | TRIB | Trinity Biotech plc | 11.66M | 3.29% | 36,293 | 56.83M |
| 57 | CNTG | Centogene N.V. | 10.52M | -5.00% | 2,556,849 | 53.93M |
| 58 | GENE | Genetic Technologies Limited | 10.10M | -0.84% | 35,475 | 5.78M |
| 59 | PRPO | Precipio, Inc. | 9.13M | -1.39% | 5,649 | 15.81M |
| 60 | XWEL | XWELL, Inc. | 7.49M | -0.82% | 5,363 | 31.77M |
| 61 | NDRA | ENDRA Life Sciences Inc. | 3.12M | -2.69% | 86,220 | - |
| 62 | ISPC | iSpecimen Inc. | 2.50M | 2.57% | 636,581 | 9.27M |
| 63 | APDN | Applied DNA Sciences, Inc. | 2.37M | -7.09% | 78,390 | 5.52M |